{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:52:01Z","timestamp":1794675121930,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P 29608"],"award-info":[{"award-number":["P 29608"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.metabol.2021.154913","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T13:41:30Z","timestamp":1634823690000},"page":"154913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals"],"prefix":"10.1016","volume":"125","author":[{"given":"Claudia A.","family":"Hana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan V.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"M\u00f6lzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"M\u00fcllner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"H\u00f6rmann-Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Franzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anela","family":"Tosevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Z\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Doberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Freisling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Moazzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154913_bb0005","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Vos","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154913_bb0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: an update","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154913_bb0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154913_bb0020","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"359","author":"Lyssenko","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154913_bb0025","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI29024","article-title":"Insulin resistance and atherosclerosis","volume":"116","author":"Semenkovich","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154913_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2012.11.001","article-title":"Bilirubin and beyond: a review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection","volume":"52","author":"Bulmer","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2021.154913_bb0035","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice with hyperbilirubinemia due to Gilbert\u2019s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1","volume":"312","author":"Hinds","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the liver\u2013gut signaling axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0045","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.2337\/db13-1652","article-title":"Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT","volume":"63","author":"Riphagen","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154913_bb0050","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1161\/STROKEAHA.109.560649","article-title":"Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women","volume":"40","author":"Kimm","year":"2009","journal-title":"Stroke."},{"issue":"29","key":"10.1016\/j.metabol.2021.154913_bb0055","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor \u03b1","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154913_bb0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1373\/clinchem.2010.151043","article-title":"Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease","volume":"56","author":"Lin","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154913_bb0065","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/db14-0228","article-title":"Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study","volume":"64","author":"Abbasi","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154913_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.2012.02576.x","article-title":"Genetically elevated bilirubin and risk of ischaemic heart disease: three M endelian randomization studies and a meta-analysis","volume":"273","author":"Stender","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2021.154913_bb0075","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.112.114066","article-title":"Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort","volume":"126","author":"Horsfall","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2021.154913_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diabet.2016.06.002","article-title":"Association of circulating total bilirubin with the metabolic syndrome and type 2 diabetes: a systematic review and meta-analysis of observational evidence","volume":"42","author":"Nano","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert\u2019s syndrome","volume":"55","author":"Wagner","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.metabol.2021.154913_bb0090","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154913_bb0095","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert\u2019s syndrome","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154913_bb0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20120661","article-title":"Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome","volume":"125","author":"Wallner","year":"2013","journal-title":"Clin Sci"},{"key":"10.1016\/j.metabol.2021.154913_bb0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2017.12.021","article-title":"Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: implications for improved metabolic health","volume":"269","author":"Khoei","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2021.154913_bb0110","doi-asserted-by":"crossref","first-page":"30051","DOI":"10.1038\/srep30051","article-title":"Features of an altered AMPK metabolic pathway in Gilbert\u2019s syndrome, and its role in metabolic health","volume":"6","author":"M\u00f6lzer","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2021.154913_bb0115","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1158\/1940-6207.CAPR-13-0125","article-title":"Anti-genotoxic potential of bilirubin in vivo: damage to DNA in hyperbilirubinemic human and animal models","volume":"6","author":"Wallner","year":"2013","journal-title":"Cancer Prevent Res (Philadelphia, Pa)"},{"key":"10.1016\/j.metabol.2021.154913_bb0120","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/eci.12120","article-title":"Haem catabolism: a novel modulator of inflammation in G ilbert\u2019s syndrome","volume":"43","author":"Wallner","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154913_bb0125","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/clinchem\/46.12.1939","article-title":"DNA base bulge vs unmatched end formation in probe-based diagnostic insertion\/deletion genotyping: genotyping the UGT1A1 (TA) n polymorphism by real-time fluorescence PCR","volume":"46","author":"von Ahsen","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2021.154913_bb0130","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3945\/jn.111.148239","article-title":"Nuclear magnetic resonance\u2013based metabolomics enable detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patients","volume":"141","author":"Moazzami","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.metabol.2021.154913_bb0135","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1021\/acs.analchem.7b04324","article-title":"AQuA: an automated quantification algorithm for high-throughput NMR-based metabolomics and its application in human plasma","volume":"90","author":"R\u00f6hnisch","year":"2018","journal-title":"Anal Chem"},{"key":"10.1016\/j.metabol.2021.154913_bb0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J R Stat Soc Ser B (Stat Methodol)"},{"key":"10.1016\/j.metabol.2021.154913_bb0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z","article-title":"Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype","volume":"16","author":"Kadakol","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2021.154913_bb0150","doi-asserted-by":"crossref","first-page":"30409","DOI":"10.1074\/jbc.R200006200","article-title":"The key role of anaplerosis and cataplerosis for citric acid cycle function","volume":"277","author":"Owen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154913_bb0155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154913_bb0160","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154913_bb0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154913_bb0170","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism\u2013emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2021.154913_bb0175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator\u2013activated receptor \u03b1 mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154913_bb0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.RES.0000256090.42690.05","article-title":"AMP-activated protein kinase in metabolic control and insulin signaling","volume":"100","author":"Towler","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154913_bb0185","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.2337\/db07-0583","article-title":"Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle","volume":"57","author":"Bouzakri","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2021.154913_bb0190","first-page":"733","article-title":"Alteration of a single amino acid in peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) generates a PPAR\u03b4 phenotype","volume":"14","author":"Takada","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2021.154913_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-\u03b1 and PPAR-\u03b3 activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154913_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin binding to PPAR\u03b1 inhibits lipid accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154913_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.594574","article-title":"Bilirubin nanoparticles reduce diet-induced hepatic steatosis, improve fat utilization, and increase plasma \u03b2-hydroxybutyrate","volume":"11","author":"Hinds","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2021.154913_bb0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","article-title":"The glucagon receptor is required for the adaptive metabolic response to fasting","volume":"8","author":"Longuet","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2021.154913_bb0220","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FPC.0b013e3280121fe9","article-title":"UGT1A1* 28 genotype affects the in-vitro glucuronidation of thyroxine in human livers","volume":"17","author":"Graber","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.metabol.2021.154913_bb0225","first-page":"2879","article-title":"Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in Man1","volume":"85","author":"Findlay","year":"2000","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.metabol.2021.154913_bb0230","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1258\/000456306778520034","article-title":"Gilbert\u2019s syndrome: an overview for clinical biochemists","volume":"43","author":"Hirschfield","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.metabol.2021.154913_bb0235","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1038\/srep09886","article-title":"Bilirubin increases insulin sensitivity by regulating cholesterol metabolism, adipokines and PPAR\u03b3 levels","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2021.154913_bb0240","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/en.2013-1667","article-title":"Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation","volume":"155","author":"Dong","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2021.154913_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2021.586715","article-title":"Mitochondrial function, fatty acid metabolism, and body composition in the hyperbilirubinemic Gunn rat","volume":"12","author":"Vidimce","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2021.154913_bb0250","first-page":"2329","article-title":"Inhibition of lipid accumulation in skeletal muscle and liver cells: a protective mechanism of bilirubin against diabetes mellitus type 2","volume":"11","author":"Hana","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2021.154913_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006503","article-title":"Circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end-stage disease (PREVEND) prospective study and a Mendelian randomization approach","volume":"6","author":"Kunutsor","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154913_bb0260","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.114.304929","article-title":"Circulating total bilirubin and risk of incident cardiovascular disease in the general population","volume":"35","author":"Kunutsor","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154913_bb0265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00392-014-0697-z","article-title":"Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: the Heinz Nixdorf Recall study","volume":"103","author":"Mahabadi","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.metabol.2021.154913_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.hjr.0000230097.81202.9f","article-title":"Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"14","author":"Troughton","year":"2007","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2021.154913_bb0275","article-title":"Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris","volume":"5","author":"Ding","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154913_bb0280","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2021.154913_bb0285","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00125-018-4599-x","article-title":"Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose","volume":"61","author":"Merino","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2021.154913_bb0290","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41467-019-08936-1","article-title":"Assessing the causal association of glycine with risk of cardio-metabolic diseases","volume":"10","author":"Wittemans","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154913_bb0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11306-010-0255-2","article-title":"Metabolomics of prolonged fasting in humans reveals new catabolic markers","volume":"7","author":"Rubio-Aliaga","year":"2011","journal-title":"Metabolomics"},{"key":"10.1016\/j.metabol.2021.154913_bb0300","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1096\/fj.11-198093","article-title":"The dynamic range of the human metabolome revealed by challenges","volume":"26","author":"Krug","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154913_bb0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/200169a0","article-title":"Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes and starvation","volume":"200","author":"Garland","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2021.154913_bb0310","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","article-title":"The Randle cycle revisited: a new head for an old hat","volume":"297","author":"Hue","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.701109","article-title":"Gilbert's syndrome and the gut microbiota \u2013 Insights from the case-control BILIHEALTH study","author":"Z\u00f6hrer","year":"2021","journal-title":"Front Cell Infect Microbiol Microbiome Health Dis"},{"key":"10.1016\/j.metabol.2021.154913_bb0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.M051680","article-title":"Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis","volume":"56","author":"Shih","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154913_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7498","article-title":"Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis","volume":"6","author":"Miao","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154913_bb0330","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cmet.2019.08.021","article-title":"Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction","volume":"30","author":"Chen","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0335","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/db06-1776","article-title":"Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis","volume":"56","author":"Bock","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2021.154913_bb0340","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cmet.2015.07.027","article-title":"Hepatic mitochondrial pyruvate carrier 1 is required for efficient regulation of gluconeogenesis and whole-body glucose homeostasis","volume":"22","author":"Gray Lawrence","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154913_bb0345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s42255-021-00369-9","article-title":"Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes","volume":"3","author":"Okun","year":"2021","journal-title":"Nat Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:15:32Z","timestamp":1777425332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521002134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":69,"alternative-id":["S0026049521002134"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154913","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154913"}}